Thursday, August 23, 2018 - 07:00

Innate Pharma SA (the “Company” - Euronext Paris: FR0010331421 – IPH) today announced a change to its 2018 financial calendar. The financial statements as of June 30, 2018 will be issued on September 14, 2018, and not on September 17 as previously announced. The remainder of the 2018 financial calendar is unchanged.

  • September 14, 2018: Publication of financial statements as of June 30, 2018
  • November 15, 2018: Publication of revenue for 3Q 2018

 

***

A conference call will be held on September 14, 2018 at 2:00pm (CEST)

Dial in numbers:

France and International: +33 (0)1 72 72 74 03       US only: +1 646 722 4916

PIN code: 53841185#

The presentation will be made available on the Company’s website 30 minutes

before the conference begins.

A replay will be available on Innate Pharma’s website after the conference call.

***

 

All corporate information on the Company, such as its financial statements and corporate presentations, is available on the Company’s website in the Investors’ section (http://www.innate-pharma.com/en/investors).

AttachmentSize
PR in English74.35 KB
CP en français76.03 KB